Concepedia

Theresa Medina

TM

Statistics

Publications

39

Citations

4.1K

H-Index

27

Active since

2008

Affiliations

University of Colorado Denver(Current)

University of Colorado Cancer Center

Moffitt Cancer Center

Angeles Clinic and Research Institute

University of Colorado Anschutz Medical Campus

Theresa Medina is an author at University of Colorado Denver specializing in oncology, immunotherapy, and cancer immunotherapy.

ORCID

Publications per year

2008–2025

39

Publications

39

Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study

Jeffrey S. Weber, Matteo S. Carlino, Adnan Khattak et al. · The Lancet · 2024 · 739 citations

, , +14

Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma

Jedd D. Wolchok, Vanna Chiarion‐Sileni, Piotr Rutkowski et al. · New England Journal of Medicine · 2024 · 480 citations · Full text

, , +14

Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma

Amod A. Sarnaik, Omid Hamid, Nikhil I. Khushalani et al. · Journal of Clinical Oncology · 2021 · 410 citations · Full text

, , +17

SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study

Antoni Ribas, Theresa Medina, Shivaani Kummar et al. · Cancer Discovery · 2018 · 341 citations · Full text

, , +17

Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study

Jason Chesney, Karl D. Lewis, Harriet M. Kluger et al. · Journal for ImmunoTherapy of Cancer · 2022 · 320 citations · Full text

, , +17

1–5 of 39